Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study
Not Applicable
Completed
- Conditions
- Endoscopic Lung Volume Reduction With Endobronchial ValveCOPD Patients With Homogeneous Emphysema
- First Posted Date
- 2013-12-31
- Last Posted Date
- 2019-08-16
- Lead Sponsor
- Pulmonx International Sàrl
- Target Recruit Count
- 93
- Registration Number
- NCT02025205
- Locations
- 🇦🇹
Ludwig-Boltzmann-Institut für COPD und Pneumologische Epidemiologie, Vienna, Austria
🇩🇪Charité Campus Virchow-Klinikum, Berlin, Germany
🇩🇪Ruhrlandklinik, Westdeutsches Lungenzentrum, Essen, Germany
Long Term Follow up Investigation of Endobronchial Valves in Emphysema
Terminated
- Conditions
- Pulmonary Emphysema
- First Posted Date
- 2012-04-18
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- Pulmonx International Sàrl
- Target Recruit Count
- 628
- Registration Number
- NCT01580215
- Locations
- 🇩🇪
Heidelberg Hospital, Heidelberg, Germany
News
No news found